Metformin Administration Versus Laparoscopic Ovarian Diathermy in Clomiphene Citrate-Resistant Women with Polycystic Ovary Syndrome: A Prospective Parallel Randomized Double-Blind Placebo-Controlled Trial
Open accessThe DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
At present, it is unclear what the role is of laparoscopic ovarian diathermy (LOD) and of metformin administration as second-line treatments for ovulation induction in women with polycystic ovary syndrome (PCOS) after failure of clomiphene citrate (CC) treatment. The aim of the present study was to compare in a randomized double-blind placebo-controlled fashion the effectiveness of LOD with metformin administration in the treatment of CC-resistant women with PCOS. A total of 120 overweight primary infertile anovulatory CC-resistant women with PCOS were enrolled and randomized into two groups of treatment. Group A underwent diagnostic laparoscopy, whereas group B underwent LOD. At hospital discharge, the patients were treated for 6 months with metformin cloridrate (group A; 850 mg twice daily) or with multivitamins (group B). The ovulation, pregnancy, abortion, and live-birth rates were evaluated. At the end of the study, the total ovulation rate was not statistically different between both treatment groups (54.8 vs. 53.2% [correction] in groups A and B, respectively), whereas the pregnancy (21.8 [correction] vs. 13.4%), the abortion (9.3 [correction] vs. 29.0%), and the live-birth (86.0 [correction] vs. 64.5%) rates were significantly (P < 0.05) different between the two groups. Our data show that metformin administration is more effective than LOD in overall reproductive outcomes in overweight infertile CC-resistant women with PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Two medium-quality RCTs (level II) with moderate risk of bias found insufficient evidence to recommend laparoscopic ovarian surgery compared with metformin for live birth rate per patient, ovulation or pregnancy rate per cycle, pregnancy rate per patient and miscarriage rate per pregnancy. 257-259”
From Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline (2011) · cites this paper as [258]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and there is no evidence-based need to continue metformin in these individuals (92)(93)(94).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [94]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“None of the currently available human insulin preparations have been demonstrated to cross the placenta (93-98).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [94]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
CLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMEN
FERRIMAN, D., & GALLWEY, J. D. (1961) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,506
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Men at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Revised American Fertility Society Classification of Endometriosis: 1985
(1985) · Fertility and Sterility · doi:10.1016/s0015-0282(16)48430-x · Cited by 1,803
Knochenhauer, E. S., Key, T. J., Kahsar-Miller, M., Waggoner, W., Boots, L. R., & Azziz, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5090 · Cited by 1,516
Knochenhauer, E. S. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.9.3078 · Cited by 1,127
Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.
Adams, J., Polson, D. W., & Franks, S. (1986) · BMJ · doi:10.1136/bmj.293.6543.355 · Cited by 981
Velazquez, E. M., Mendoza, S., Hamer, T., Sosa, F., & Glueck, C. J. (1994) · Metabolism · doi:10.1016/0026-0495(94)90209-7 · Cited by 865
Cited by
Items 101–177 of 177
Gut Hormones, Obesity, Polycystic Ovarian Syndrome, Malignancy, and Lipodystrophy Syndromes
Bloomgarden, Z. T. (2007) · Diabetes Care · doi:10.2337/dc07-zb07 · Cited by 12
Ovulation Induction in Anovulatory Patients with Polycystic Ovary Syndrome
Palomba, S., Falbo, A. I., Russo, T., & Zullo, F. (2006) · Current Drug Therapy · doi:10.2174/157488506775268498 · Cited by 8
el Sharkwy, I. A. E. (2013) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2012.12.008 · Cited by 9
Effects of insulin-lowering drugs in PCOS: endocrine, metabolic and inflammatory aspects
Rautio, K. (2006) · Cited by 7
Sun, M., Bai, W., Song, Q., Wang, H., Gao, G., Zheng, L., & Wang, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.576458 · Cited by 9
“Nevertheless, some patients with PCOS show CC resistance (CCR), defined as failure to achieve ovulation after the dose of CC has been gradually increased to 150 or 250 mg/day—the final dosage differed among the studies—in at least three consecutive cycles (Malkawi et al., 2003; Palomba et al., 2004; Palomba et al., 20…”
BackgroundMethodInfluentialWang, X., Wang, J., Xu, Y., & Huang, L. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3486-z · Cited by 7
“The first study found that there were no significant differences in the rates of ovulation and pregnancy after Met and LOD therapy, respectively [13]; while the other study suggested that patients who received Met therapy would have a higher pregnancy rate [14].”
InfluentialRetractedCurrent procedures for managing polycystic ovary syndrome
Massicotte, M.-H., Langlois, F., & Baillargeon, J. (2010) · Expert Review of Obstetrics & Gynecology · doi:10.1586/eog.09.74 · Cited by 5
Palomba, S., Zullo, F., Diamanti‐Kandarakis, E., & Orio, F. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_14 · Cited by 6
“Analyzing the costs of two procedures, metformin administration was at least 20-fold less expensive then LOD ( 84 ).”
BackgroundNestler, J. E. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0113 · Cited by 5
Ovulation induction in women with polycystic ovary syndrome
Nader, S. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0510 · Cited by 5
Le drilling ovarien dans le traitement des ovaires polykystiques
Gervaise, A., & Fernandez, H. (2005) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2005.07.010 · Cited by 5
Surgical aspects of treating polycystic ovary syndrome
Andreeva, E. N., Sheremetyeva, E. V., & Arakelyan, A. S. (2020) · Russian Journal of Human Reproduction · doi:10.17116/repro20202605165 · Cited by 4
Salivary versus serum approaches in assessment of biochemical hyperandrogenemia
El-Gharib, M., & Hazaa, S. (2014) · Journal of Basic and Clinical Reproductive Sciences · doi:10.4103/2278-960x.129283 · Cited by 4
“[4‐6] Although saliva has not yet become a mainstream sample source for hormone analysis, it has proven to be reliable and in some cases, even superior to other body fluids.”
BackgroundSurgical Ovulation Induction in Women with Polycystic Ovary Syndrome: A Systematic Review
Frank, V., Rajaeefard, A., Jaafarzadeh, A., Sayadi, M., Zarei, A., Parsanezhad, M. E., & Schmidt, E. H. (2009) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 4
Laparoscopic ovarian drilling for polycystic ovarian syndrome: treatment outcome.
Hameed, N., & Ali, M. A. (2012) · PubMed · Cited by 3
Metformin ameliorates endometrial thickness in a rat model of thin endometrium
Imran, M. J., Khandvilkar, A., Metkari, S., Sachdeva, G., & Chaudhari, U. K. (2024) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13862 · Cited by 4
Síndrome de ovario poliquístico e infertilidad
Silva, V. (2010) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(10)70549-6 · Cited by 12
Strategies for Ovulation Induction in the Management of Anovulatory Polycystic Ovary Syndrome
Frcog, A. B. M. (2007) · Springer eBooks · doi:10.1007/978-0-387-69248-7_7 · Cited by 3
“An interesting study of 120 CC-citrate-resistant women found no significant difference in rates of ovulation when LOD was compared with metformin therapy (approximately 55% in each group), yet those treated with metformin had higher pregnancy rates (18.6% versus 13.4%) and live birth rates (82.1% versus 64.5%) [47], a…”
ResultInfluentialInsulin sensitizers for women with polycystic ovarian syndrome
Galal, A. F., & Mitwally, M. F. (2009) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.4.2.183 · Cited by 4
Ovulation Induction in Anovulatory Patients with Polycystic Ovary Syndrome
Falbo, A. I., Palomba, S., Russo, T., Cello, A. D., & Zullo, F. (2010) · Journal of South Asian Federation of Obstetrics and Gynaecology · doi:10.5005/jp-journals-10006-1092 · Cited by 4
“Finally, a recent RCT has shown that LOD is less effective and more expensive than metformin in CCresistant PCOS women [ 56 ].”
BackgroundInsulin-Sensitizing Drugs for the Treatment of Infertility in Polycystic Ovary Syndrome
Ryan, C. S., & Nestler, J. E. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_10 · Cited by 4
A 40-Year-Old Woman With Diabetes Contemplating Pregnancy After Gastric Bypass Surgery
Coustan, D. R. (2008) · JAMA · doi:10.1001/jama.299.17.jrr80003 · Cited by 3
Polycystic Ovary Syndrome: Update on Treatment Options and Treatment Considerations for the Future
Farrell-Turner, K. A. (2011) · Clinical Medicine Insights Women s Health · doi:10.4137/cmwh.s6715 · Cited by 3
Actualités en endocrinologie de la reproduction
Christin‐Maître, S. (2005) · EMC - Endocrinologie · doi:10.1016/j.emcend.2005.08.002 · Cited by 3
Insulin Resistance in Children and in the Polycystic Ovarian Syndrome
Bloomgarden, Z. T. (2005) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2005.3.294 · Cited by 2
Palomba, S., Orio, F., Falbo, A. I., Russo, T., Lombardi, G., & Zullo, F. (2004) · Human Reproduction · doi:10.1093/humrep/deh468 · Cited by 2
Baillargeon, J., & Farid, N. R. (2009) · Springer eBooks · doi:10.1007/978-0-387-09718-3_18 · Cited by 2
An, J., Zhou, Q., Liu, X., Ren, J., Cheng, Y., Liu, Y., & Cao, Z. (2025) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.2025.j084 · Cited by 1
The Current Status for Metformin Use in Reproductive Medicine
Legro, R. S. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1436-1_12 · Cited by 1
“The Italian group in another small trial did report a significant reduction in miscarriage rates in clomiphene resistant women who conceived after metformin use, compared to laparoscopic diathermy [ 18 ].”
ResultRole of Insulin-Sensitizing Drugs in PCOS Management
Awwad, J. T., & Ghazeeri, G. S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8394-6_10 · Cited by 2
Traitements adjuvants en stimulation ± insémination
Alvarez, S. (2010) · Gynécologie Obstétrique & Fertilité · doi:10.1016/s1297-9589(10)70010-2 · Cited by 1
Strowitzki, T. (2008) · Gyn�kologisch-geburtshilfliche Rundschau · doi:10.1159/000111464 · Cited by 1
“Zwischen LOD und Gonadotropinstimulation fanden sich keinerlei Unterschiede bezuglich der Lebendgeburtrate (Chancenverhaltnis 1,04) und der klinischen Schwangerschaftsrate (Chancenverhaltnis 1,08). Die Mehrlingsrate war aber nach LOD signifikant niedriger (1 vs. 16p nach Gonadotropinstimulation), die Abortrate untersc…”
BackgroundUso de la metformina en el tratamiento de pacientes infértiles con síndrome de ovarios poliquísticos
Giustiniano, B., Rodríguez, S., Abache, E., & Hurtado, F. B. (2010) · Revista de Obstetricia y Ginecología de Venezuela · Cited by 1
Reproductive surgery in infertile women
Taşkın, S., Tolunay, H. E., & Sönmezer, M. (2013) · Expert Review of Obstetrics & Gynecology · doi:10.1586/17474108.2013.828885 · Cited by 1
Considerations and Challenges for Pregnancy in Polycystic Ovary Syndrome
Han, C. S., & Werner, E. F. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8394-6_15 · Cited by 1
Use of Insulin Sensitizers in the Polycystic Ovary Syndrome
Cheang, K. I., & Nestler, J. E. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-179-6_38 · Cited by 1
“Recently, metformin has been compared to laparoscopic ovarian diathermy in overweight (BMI 25–40 kg/m 2 ), clomiphene-resistant women with PCOS ( 27 ).”
BackgroundOvarian Cautery for Polycystic Ovary Syndrome
Kovacs, G. T. (2022) · Cambridge University Press eBooks · doi:10.1017/9781316477021.027 · Cited by 1
Pregnancy in Polycystic Ovary Syndrome
Homburg, R. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-108-6_20 · Cited by 1
Eskiyörük, İ., Melekoğlu, R., Çetin, C., Ürünsak, İ. F., & ÇETİN, M. T. (2018) · Türk Üreme Tıbbı ve Cerrahisi Dergisi · doi:10.24074/tjrms.2018-62975 · Cited by 1
Evidence-based reproductive medicine in clinical practice: the case of clomiphene-resistant PCOS
van Tetering, E. A. A., van Dessel, H. J. H. M., & Mol, B. W. (2005) · European Clinics in Obstetrics and Gynaecology · doi:10.1007/s11296-005-0014-5 · Cited by 1
“After you scan the abstracts, two potentially relevant articles out of the original 14 remain: a study comparing metformin versus LEO and a study comparing recombinant FSH versus LEO [ 13 , 14].”
BackgroundGuadix, B. R., Navarro, L. M., Rodríguez, M. Á. C., Jiménez, J. F., de la Cruz, R. L.-J. R., & López‐Criado, M. S. (2009) · Progresos de Obstetricia y Ginecología · doi:10.1016/s0304-5013(09)70341-3 · Cited by 2
Polycystic Ovary Syndrome and the Metabolic Syndrome
Janssen, O. E., Tan, S., Dietz, T., & Hahn, S. (2007) · CRC Press eBooks · doi:10.3109/9780849379581-37 · Cited by 1
Reproductive and Obstetrical Consequences of the Polycystic Ovary Syndrome
Johnson, M. C., & Legro, R. S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-179-6_30
“Small randomized trials of pregnancy and pregnancy outcomes have shown lower pregnancy loss rates in pregnancies conceived with metformin (18, 24 ) compared with conventional treatments, providing support for the idea of insulin resistance contributing to pregnancy loss in these women.”
BackgroundChirurgia endoscopica: un update
Palomba, S., & Zullo, F. (2006) · CNR Solar (Scientific Open-access Literature Archive and Repository) (Consiglio Nazionale delle Ricerche)
Mild forms of ovarian stimulation
Aboulghar, M. A., & Rizk, B. M. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511762390.004 · Cited by 2
van Santbrink, E. J. P., & Fauser, B. C. J. M. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511547287.025 · Cited by 2
Surgical Management of the Polycystic Ovary Syndrome
Balen, A. H. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-179-6_37
“found no significant difference in rates of ovulation (approximately 55% in each group), yet those treated with metformin had significantly higher pregnancy rates (18.6 vs 13.4%, p 28 ).”
ResultInfluentialRecommandations pour le diagnostic et le suivi du syndrome des ovaires polykystiques
Théron-Gérard, L., Cédrin‐Durnerin, I., & Hugues, J. (2008) · EMC - Gynécologie · doi:10.1016/s0246-1064(08)44358-x
Recomendaciones para el diagnóstico y el seguimiento del síndrome de ovarios poliquísticos
Théron-Gérard, L., Cédrin‐Durnerin, I., & Hugues, J. (2008) · EMC - Ginecología-Obstetricia · doi:10.1016/s1283-081x(08)70803-8 · Cited by 1
Wang, X., Wang, J., Xu, Y., & Huang, L. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-016-4022-0
Li, C., Cheng, J., Wang, J., Xue, Y., Huang, Z., Zhang, S., & Lv, J. (2011) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-011-1924-8
“The loss of early gestation has been reduced in PCOS patients after treatment with metformin [30].”
BackgroundChadha, G. (2012) · Apollo Medicine · doi:10.1016/j.apme.2012.07.004
Une alternative pour traiter l’infertilité : le drilling ovarien
Fernandez, H. (2009) · Gynécologie Obstétrique & Fertilité · doi:10.1016/s1297-9589(09)71513-9
Aktuelle Therapieansätze für das PCO-Syndrom bei Insulinresistenz
Ludwig, M. Z. (2005) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Position of alternatives: insulin sensitizers and others
van Zonneveld, P. (2005) · International Congress Series · doi:10.1016/j.ics.2004.12.041
“Also direct comparisons with CC as a first-line treatment, as well as with gonadotrophins and laparoscopic ovarian diathermy [10], are needed.”
BackgroundEffective Regimens for Ovulation Induction in Polycystic Ovary Syndrome
Tapanainen, J. S., & Morin-Papunen, L. C. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-108-6_19 · Cited by 1
“Prospective randomized controlled studies have shown a significant fourfold decrease (9.7 vs. 37.5%) in miscarriage rates compared with CC treatment in non-obese women with PCOS (56) and a twofold decrease (15.4 vs. 29.0%) compared with laparoscopic ovarian drilling (LOD) in obese women with PCOS ( 70 ).”
BackgroundResultInfluentialReasner, C. A. (2013) · CRC Press eBooks · doi:10.3109/9781420019667-17 · Cited by 1
Alvarez, S. (2007) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2007.07.014
Ovulation induction for anovulatory patients
van Santbrink, E. J. P., & Fauser, B. C. J. M. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511762390.005
Polycystic ovary syndrome: managing the basics
Hansen, K. A. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139649520.005
Indication of Laparoscopic ovarian drilling
幸代, 野., 博, 林., 江崎, 敬., 楠原, 淳., 絵理, 高., 三沢, 昭., 信依, 大., 高田, 全., 公平, 杉., 尚江, 遠., et al. (2007) · JAPANESE JOURNAL OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY · doi:10.5180/jsgoe.23.257
Majeed, B. M., & Saleh, R. A. (2012) · The Medical Journal of Tikrit University
MaNEjo dEl SíNdroME dE ovario P oliqUíStiCo EN la MUjEr iNfértil
Revisión, T. D. (2008)
Palomba, S., Falbo, A. I., & Sala, G. B. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-45534-1_11
Polycystic ovary syndrome - Metformin treatment in pregnancy
Vanky, E. (2005) · NVA (Nasjonalt vitenarkiv)
(2006) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/01.gco.0000193023.28556.e2
(2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3280d5f7e9
Gibson, M. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1436-1_35
Ovulation Induction for Anovulatory Patients
van Santbrink, E. J. P., & Fauser, B. C. J. M. (2022) · Cambridge University Press eBooks · doi:10.1017/9781316477021.005
Considerations and Challenges for Pregnancy in Polycystic Ovary Syndrome
Holliman, K., Wu, E., & Han, C. S. (2022) · Springer eBooks · doi:10.1007/978-3-030-92589-5_16
Role of Insulin-Sensitizing Drugs in PCOS Management
Kojok, D., Ghazeeri, G. S., & Awwad, J. T. (2022) · Springer eBooks · doi:10.1007/978-3-030-92589-5_12 · Cited by 1
van Wely, M., Bayram, N., van der Veen, F., & Bossuyt, P. M. (2004) · Human Reproduction · doi:10.1093/humrep/deh469
“We look forward to the publication of the randomized trial by Palomba et al. (2004) in which metformin is compared with laparoscopic electrocautery in CC-resistant women with PCOS.”
BackgroundOvarian Surgery for Ovulation Induction
Kovacs, G. T. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108989831.012
Reasner, C. A. (2006) · Fundamental and clinical cardiology · doi:10.3109/9781420019667.011
Review on Polycystic Ovarian Syndrome (PCOS) In Case of Pregnancy
-, T. G. N., -, D. G. A., -, T. M. S., & -, S. P. J. (2023) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2023.v05i05.8005
Syndrome des ovaires polykystiques
Hugues, J. (2011) · Springer eBooks · doi:10.1007/978-2-8178-0061-5_17
The Effect of PCOS on Fertility and Pregnancy
Salley, K. E. S., & Nestler, J. E. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-250-6_10
Metadata
- Authors
- Palomba, S., Orio, F., Nardo, L. G., Falbo, A., Russo, T., Corea, D., Doldo, P., Lombardi, G., Tolino, A., Colao, A., & Zullo, F.
- Affiliations
- Magna Graecia University (IT)
- St Mary's Hospital (GB)
- Federico II University Hospital (IT)
- Corresponding author
- Palomba, Stefano
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-10
- Volume
- 89
- Issue
- 10
- Pages
- 4801-4809
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2113943040
- Cited by
- 177
- References
- 86
- Citations by year
- 2025: 4 · 2024: 2 · 2023: 2 · 2022: 7 · 2021: 2 · 2020: 4 · 2019: 4 · 2018: 5 · 2017: 3 · 2016: 2 · 2015: 4 · 2014: 4 · 2013: 6 · 2012: 8
- FWCI
- 20.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (Parthenope University of Naples) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Zenodo (CERN European Organization for Nuclear Research) (other-oa)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Keywords
- metformin, polycystic ovary syndrome, clomiphene citrate resistance, ovulation induction, anovulatory infertility, pregnancy rate, live birth rate, abortion rates, ovulation rate, overweight women
- MeSH terms
- Adult, Ambulatory Surgical Procedures, Clomiphene, Double-Blind Method, Drug Resistance, Electrocoagulation, Female, Fertility Agents, Female, Humans, Hypoglycemic Agents, Metformin, Patient Dropouts, Laparoscopy, Placebos, Polycystic Ovary Syndrome, Pregnancy, Pregnancy Outcome, Prospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.